Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan A Grupp

Showing results (11-20 of 238) with videos related to

Pageof 24
Sort By:
Nature Reviews. Clinical Oncology|February 20, 2021
Will allogeneic CAR T cells for CD19<sup>+</sup> malignancies take autologous CAR T cells 'off the shelf'?Amanda M DiNofia, Stephan A Grupp
Gene Therapy|July 2, 2018
CAR-T in the clinic: drive with careRafael J Yáñez-Muñoz, Stephan A Grupp
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Neuroblastoma: issues in transplantationStephan A Grupp, Shahab Asgharzadeh, Gregory A Yanik
Pediatric Clinics of North America|March 24, 2010
Autologous and allogeneic cellular therapies for high-risk pediatric solid tumorsDavid Barrett, Jonathan D Fish, Stephan A Grupp
Oncoimmunology|May 13, 2015
Roadblocks to success for RNA CARs in solid tumorsNathan Singh, David M Barrett, Stephan A Grupp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2023
Reply to W.H. Tong et alTheodore W Laetsch, Ranjan Tiwari, Stephan A Grupp
Nature Reviews. Clinical Oncology|November 15, 2024
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocksCaroline Diorio, David T Teachey, Stephan A Grupp
Hematology. American Society of Hematology. Education Program|February 20, 2015
Chimeric antigen receptor T-cell therapy for ALLShannon L Maude, Elizabeth J Shpall, Stephan A Grupp
Journal of Immunology (Baltimore, Md. : 1950)|July 19, 2015
Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall StreetDavid M Barrett, Stephan A Grupp, Carl H June
British Journal of Haematology|November 26, 2009
Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)David T Teachey, Alix E Seif, Stephan A Grupp
Pageof 24

Showing results (11-20 of 238) with videos related to

Sort By:
Pageof 24
Nature Reviews. Clinical Oncology|February 20, 2021
Will allogeneic CAR T cells for CD19<sup>+</sup> malignancies take autologous CAR T cells 'off the shelf'?Amanda M DiNofia, Stephan A Grupp
Gene Therapy|July 2, 2018
CAR-T in the clinic: drive with careRafael J Yáñez-Muñoz, Stephan A Grupp
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 10, 2012
Neuroblastoma: issues in transplantationStephan A Grupp, Shahab Asgharzadeh, Gregory A Yanik
Pediatric Clinics of North America|March 24, 2010
Autologous and allogeneic cellular therapies for high-risk pediatric solid tumorsDavid Barrett, Jonathan D Fish, Stephan A Grupp
Oncoimmunology|May 13, 2015
Roadblocks to success for RNA CARs in solid tumorsNathan Singh, David M Barrett, Stephan A Grupp
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2023
Reply to W.H. Tong et alTheodore W Laetsch, Ranjan Tiwari, Stephan A Grupp
Nature Reviews. Clinical Oncology|November 15, 2024
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocksCaroline Diorio, David T Teachey, Stephan A Grupp
Hematology. American Society of Hematology. Education Program|February 20, 2015
Chimeric antigen receptor T-cell therapy for ALLShannon L Maude, Elizabeth J Shpall, Stephan A Grupp
Journal of Immunology (Baltimore, Md. : 1950)|July 19, 2015
Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall StreetDavid M Barrett, Stephan A Grupp, Carl H June
British Journal of Haematology|November 26, 2009
Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS)David T Teachey, Alix E Seif, Stephan A Grupp
Pageof 24